The new White House policy bans federal funding for dangerous gain of function research and reshapes oversight for high-risk science.
The new White House policy bans federal funding for dangerous gain of function research and reshapes oversight for high-risk science.
CMS proposes major changes to how states structure healthcare-related taxes, aiming to tighten oversight and reduce federal spending over the next decade.
By voluntarily self-disclosing the violations and cooperating with the DOJ, the testing laboratory avoided open-ended exposure, a corporate integrity agreement, and exclusion from federal programs.
The Department of Health and Human Services announced it will temporarily withhold certain Medicaid payments from the Democrat-led states while reviewing potential fraud and compliance concerns.
Major changes to physician payment, quality reporting, and accountable care in Centers for Medicare & Medicaid Services’ 2027 proposed rule.
An external audit of the insurers in-home assessment program for Medicare Advantage seniors found nearly all diagnoses made during visits were supported by medical records.
Healthcare organizations might think the delay in HIPAA changes will buy them time before having to deal with compliance issues, but legal and data security experts advise against putting them off.
The panel, which typically convenes three times per year to review scientific evidence on preventive screenings and treatments, has not met in person since March 2025.